Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Drug Discoveries & Therapeutics|July 13, 2018
D-cycloserine nasal formulation development for anxiety disorders by using polymeric gelsYeonoh Shin, Rutika Kokate, Vilas Desai, et al.
Nanoscale|November 9, 2013
Resonance energy transfer between fluorescent BSA protected Au nanoclusters and organic fluorophoresSangram Raut, Ryan Rich, Rafal Fudala, et al.
Plos One|May 14, 2013
Long-lived bright red emitting azaoxa-triangulenium fluorophoresBadri P Maliwal, Rafal Fudala, Sangram Raut, et al.
European Urology Oncology|July 6, 2022
Neoadjuvant Chemotherapy with Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients with Muscle-invasive Bladder Cancer: A Retrospective Age-stratified Analysis on Safety and EfficacyGregory Hemenway, Bianca Lewis, Pooja Ghatalia, et al.
American Journal of Clinical Oncology|May 17, 2024
Multidisciplinary Educational Program to Standardize Education and Management of Immune-related Adverse Events: Review and Outcomes of a Single-institution InitiativeMatthew Zibelman, Victoria Wong, Jennifer Reilly, et al.
European Urology|July 13, 2024
Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 TrialElizabeth R Plimack, Catherine Tangen, Melissa Plets, et al.
The Journal of Urology|February 4, 2021
Cystoscopy and Systematic Bladder Tissue Sampling in Predicting pT0 Bladder Cancer: A Prospective TrialMatthew Zibelman, Aeen M Asghar, Daniel C Parker, et al.
Nature Communications|July 27, 2023
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumorsMatthew Zibelman, Alexander W MacFarlane, Kimberly Costello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2023
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor TherapyH Josh Jang, Galen Hostetter, Alexander W Macfarlane, et al.
Pageof 1